Medical Incubator Japan K.K.


Medical Incubator Japan K.K. is a venture capital firm specializing in healthcare investments. The firm is dedicated to discovering and supporting innovative startups that have the potential to transform the standard of care in the medical field. By investing in cutting-edge technologies, Medical Incubator Japan aims to bring new value to patients and generate returns for investors. The firm focuses on biotechs developing first-in-class or best-in-class pharmaceuticals, as well as companies innovating in digital health and AI technologies.

Medical Incubator Japan K.K.

Medical Incubator Japan K.K.

JMF-Bldg. Akasaka 01 8fl., 1-11-28, Akasaka, Minato-ku, Tokyo 107-0052


What We Do

MIJ has built a strong network in the healthcare ecosystem community in the UK, Israel, and Japan, and searches for promising biotechs in other areas through reliable local sources.

The team consists of private equity investment experts in healthcare, including management professionals, investment professionals with successful exits, AI experts, entrepreneurs with IPO experience, and experienced ex-examiners at the PMDA.

MIJ provides strategies for investees in planning and executing intellectual property, fundraising, R&D, clinical trials, regulatory, alliance activities, product distribution, and sales and marketing.


Investment Stage


Portfolio

Hoba Therapeutics is dedicated to innovative treatments for chronic pain disorders and sensorineural hearing loss.

#Biotechnology

Provides physicians and medical professionals with clinical practice information and solutions for pharmaceutical companies.

#Healthcare Information

Develops regenerative cell drugs for central nervous system injuries or diseases.

#Regenerative Medicine

Develops therapeutic drugs for genetic diseases using CRISPR technology.

#Genome Editing

Develops gene therapeutic adipocyte medicines for genetic enzyme and protein deficiencies.

#Gene Therapy

Focuses on innovative gene therapies using adeno-associated virus (AAV) vectors.

#Gene Therapy


Key People

President / CEO

Director / Investment Officer

Director / Investment Officer